US Archives - Page 7 of 130 - European Medical Journal

Six Months to Better Outcomes in Vitiligo?

Oral JAK inhibitors appear effective and safe in the treatment of vitiligo, according to a retrospective study evaluating real-world outcomes in nearly 100 patients.

How a Global Consensus Is Redefining COVID-19 Treatment for Organ Recipients

Solid organ transplant (SOT) recipients face a heightened risk of severe outcomes from SARS-CoV-2 infection, yet clinical evidence specific to this vulnerable group remains limited.

Survey Reveals Key Obstacles to Cancer Research

Clinical cancer research across the Asia-Pacific region faces substantial barriers, with competing demands, lack of funding, and limited infrastructure emerging as the most significant obstacles, according to a large cross-sectional survey of healthcare professionals.

Sex Differences Shape Huntington’s Disease Progression

Sex-specific differences significantly influence the progression of Huntington’s disease (HD), according to new findings that highlight the role of the cytosine-adenine-guanine-age product score (CAPS) in shaping both clinical outcomes and brain changes.

Machine Learning Improves Prediction of Urgent Care in Lung Cancer

Machine learning can help predict urgent care visits in patients with non–small cell lung cancer receiving systemic therapy.

23 Sep 2025

IL-5 in Focus: A New View on Type 2 Inflammation

This interactive infographic explores how IL-5 contributes to Type 2 inflammation in severe asthma. Discover IL-5’s effects on immune cells beyond eosinophils, and the clinical consequences.

Signals in Blood and Spinal Fluid Linked to Cerebral Palsy Risk

Could molecules in the blood and spinal fluid hold the key to understanding cerebral palsy?

Canakinumab Outperforms Anakinra in VEXAS Syndrome

Canakinumab demonstrated significantly greater efficacy and durability than anakinra in the treatment of patients with VEXAS syndrome, according to findings from an international multicenter study.

Oral Health Still Burdens Long-Term Cancer Survivors

Long-term head and neck cancer survivors frequently report poor oral health-related quality of life, with persistent late toxicities remaining common more than 8 years after diagnosis.

Combined Brain Stimulation and Therapy Boosts Stroke Recovery

Patients with aphasia caused by stroke or traumatic brain injury experienced the greatest improvements in language recovery when transcranial direct current stimulation (tDCS) was combined with speech-language therapy (SLT).